Cancer is no longer automatically a death sentence
Cancer has quietly become the defining medical crisis of our age — not because it is new, but because it now claims more lives each year than HIV, tuberculosis, and malaria combined, touching the powerful and the powerless alike. The death of beloved Nigerian actor Alex Ekubo at forty in 2026 stripped away the comfortable distance many had kept from the disease, forcing a reckoning long overdue. With nearly twenty million new cases recorded globally in 2022 and projections pointing toward thirty-five million annually by 2050, humanity stands at a crossroads where the choices made today — in clinics, in policy halls, in households — will determine how many futures remain possible.
- Cancer is no longer a distant threat — the very public loss of Alex Ekubo shattered the illusion that youth, fame, or vitality offer protection, sending a wave of grief and urgency through Nigeria and beyond.
- In Nigeria, over 120,000 new cases emerge each year, yet most patients arrive at hospitals only after exhausting prayer houses and herbal remedies, by which point the disease has already advanced to stages far harder to treat.
- The financial toll is catastrophic — families sell land, drain savings, and launch public fundraising campaigns to afford a single chemotherapy cycle, while nearly ninety percent of healthcare costs fall directly on patients' pockets.
- Survivors like Wole Soyinka, Ngozi Okonjo-Iweala, and Banky W are actively dismantling the stigma of silence, proving that early detection and treatment can lead to full recovery and urging others not to delay seeking care.
- New oncology centers, telemedicine platforms, and government partnerships are beginning to close the treatment gap in Nigeria, but experts warn these efforts remain far too small against the scale of the crisis.
- The trajectory points toward hope only if prevention, education, and equitable healthcare investment are treated as urgent national and global priorities — because the science is advancing faster than the systems meant to deliver it.
In hospitals from Lagos to London, a diagnosis arrives and everything changes in an instant. Cancer has become the defining medical crisis of our time — a disease that respects no border, no bank account, no amount of fame. When Nollywood actor Alex Ekubo died in May 2026 at forty from kidney cancer, fought in private and lost in silence, Nigeria could no longer look away. Globally, nearly twenty million new cases emerged in 2022 alone, with 9.7 million deaths. Without urgent intervention, annual cases could reach thirty-five million by 2050.
Nigeria's burden is especially severe. More than 120,000 new cases are recorded each year, with close to 80,000 deaths. Breast cancer leads among women; prostate cancer dominates among men. What makes the crisis particularly acute is not just the volume of cases but the timing of diagnosis — many patients first seek help from prayer houses or traditional healers, arriving at hospitals only when cancers are already advanced. Treatment costs then devastate what remains. A single chemotherapy cycle can cost hundreds of thousands of naira. Families sell land, drain savings, and organize public fundraising campaigns. Others abandon treatment entirely.
Yet the story is not one of hopelessness alone. Wole Soyinka, Ngozi Okonjo-Iweala, and singer Banky W have each spoken openly about surviving cancer through early detection and treatment, challenging the stigma that keeps people from seeking help. Medical advances — immunotherapy, targeted therapy, stem cell transplants, and the emerging promise of AI-driven genetic profiling — have transformed what survival can look like.
The tragedy is that survival still depends largely on geography and wealth. Africa's mortality rates remain disproportionately high despite lower case volumes, because patients present late and treatment infrastructure remains thin. Nigeria is responding — new oncology centers are being developed, telemedicine platforms are connecting patients with specialists remotely, and government partnerships are expanding screening access. But experts insist far greater investment is needed. Prevention, education, and equitable healthcare access are not secondary concerns — they are the front line of a battle that medicine alone cannot win.
In hospitals across the world—from Lagos to London, Tokyo to New York—families wake each morning to the same dread. A diagnosis arrives, and within seconds, everything changes. Cancer has become the defining medical crisis of our time, a disease that respects no border, no bank account, no amount of fame.
When Nollywood actor Alex Ekubo died in May 2026 at forty, the news shattered the illusion that cancer was something that happened to other people. For months, fans had wondered why one of Nigeria's most visible stars had vanished from public life. Then came the confirmation: kidney cancer, fought in private, lost in silence. His death forced a conversation Nigeria could no longer avoid. The disease kills more people globally each year than HIV, tuberculosis, and malaria combined. In 2022 alone, nearly twenty million new cases emerged worldwide, with 9.7 million deaths. By 2050, without urgent intervention, annual cases could reach thirty-five million.
Nigeria's burden is particularly severe. The country records more than 120,000 new cancer cases yearly and close to 80,000 deaths. Breast cancer leads among women, accounting for over a quarter of new diagnoses. Prostate cancer dominates among men. Cervical, colorectal, liver, and lymphoma cases round out the grim landscape. The disease develops when the body's orderly system of cell growth and death breaks down. Abnormal cells multiply uncontrollably, invading tissues, damaging organs, spreading through blood and lymph in a process called metastasis. Unlike healthy cells, cancer cells ignore the signals telling them to stop. They evade the immune system. They survive when they should die. Scientists have struggled for decades to find a universal cure because cancer is not one disease—it is hundreds, each with different causes, behaviors, and outcomes.
What makes Nigeria's crisis particularly acute is not just the volume of cases but the timing of diagnosis. Many patients first seek help from prayer houses, traditional healers, or herbal centers before reaching hospitals. By then, cancers are already advanced. Fear compounds the delay. Some avoid screening because they dread bad news. Others wrongly believe cancer automatically means death. When patients finally arrive at hospitals, treatment costs devastate families. A single chemotherapy cycle may cost hundreds of thousands of naira. Advanced surgeries, radiotherapy, and long-term medications push costs into millions. Nearly ninety percent of healthcare spending in Nigeria comes directly from patients' pockets. Families sell land, drain savings, organize public fundraising campaigns. Others simply abandon treatment because they cannot afford it.
Yet the story is not one of hopelessness alone. Wole Soyinka, Nigeria's Nobel laureate, publicly disclosed in 2014 that he survived cancer after early detection and treatment. "Cancer is curable," he said. Ngozi Okonjo-Iweala revealed she had battled cancer for years before becoming cancer-free through surgery, chemotherapy, and radiotherapy. Singer Banky W shared photographs of his surgical scars as evidence of survival. These voices matter because they challenge the stigma that keeps people from seeking help. Medical advances have transformed treatment options. Surgery remains effective when cancers are caught early. Chemotherapy, radiation therapy, hormone therapy, and targeted therapy each play roles depending on the disease. Immunotherapy, one of the most important breakthroughs in recent years, helps the body's immune system recognize and attack cancer cells more effectively. Stem cell transplants treat blood cancers. Doctors often combine several methods to improve survival chances.
The tragedy is that survival depends largely on where a person lives and how much money they have. Developed countries with stronger screening systems and better healthcare access record higher diagnosis rates but lower death rates. Poorer countries suffer disproportionately high mortality because patients present late and treatment facilities remain inadequate. Africa vividly illustrates this imbalance. Though the continent accounts for a smaller percentage of global cancer cases compared to Europe or North America, mortality rates remain significantly higher due to weak healthcare systems, limited awareness, poverty, and poor access to specialized treatment. Nigeria is attempting to address this gap. The Federal Government has launched initiatives to improve diagnosis, screening, and treatment access. The Nigerian Sovereign Investment Authority partnered with Lagos University Teaching Hospital to establish advanced cancer treatment facilities. New oncology and diagnostic centers are being developed across the country's geopolitical zones. Telemedicine platforms like Oncopadi are connecting cancer patients with doctors remotely, bridging geographical barriers. Non-governmental organizations continue organizing awareness campaigns and free screening programs.
But experts insist much more investment is needed. The future fight against cancer will depend heavily on prevention, education, and improved healthcare access. Reducing smoking rates, encouraging healthier diets, increasing physical activity, promoting vaccination against HPV and hepatitis, and expanding early screening programs could save millions of lives over coming decades. Artificial intelligence and genetic research are transforming diagnosis and treatment globally. Scientists are developing personalized treatments tailored to individual patients based on genetic profiling. Yet the greatest challenge may not be scientific at all. It lies in changing public attitudes. Because despite the fear surrounding the disease, doctors insist cancer is no longer automatically a death sentence. The earlier it is detected, the better the chances of survival. In that fragile space between diagnosis and hope, humanity continues one of its most important battles—the fight against a disease that has come to redefine medicine, mortality, and the value of life itself.
Notable Quotes
Cancer is curable. Many people think it is a death sentence, but it is not.— Wole Soyinka, Nobel laureate and cancer survivor
I underwent surgery, chemotherapy and radiotherapy. I am a cancer survivor.— Ngozi Okonjo-Iweala, former Director-General of the WTO
The Hearth Conversation Another angle on the story
Why does cancer feel different now than it did twenty years ago?
Because it's everywhere. It's not a rare diagnosis anymore—it's the disease your neighbor has, your colleague, your favorite actor. Twenty million new cases a year globally. That visibility changes everything. People can't pretend it's someone else's problem.
But medicine has gotten better, hasn't it? We have more treatments now.
Yes, and that's real. Immunotherapy, targeted drugs, better surgery. Early detection genuinely saves lives. But here's the cruel part: those advances mostly exist in wealthy countries. In Nigeria, a patient might never reach a hospital in time to benefit from them.
So it's not really a medical problem. It's an access problem.
It's both. The disease itself is complex—hundreds of different cancers, each behaving differently. But yes, survival depends more on your zip code and your bank account than on the science. That's the injustice.
What changed with people like Wole Soyinka speaking publicly about surviving cancer?
Stigma dissolved a little. When a Nobel laureate says "I had cancer and I'm alive," it breaks the silence. People stop assuming diagnosis means death. They start asking about screening, about early detection. Fear becomes less paralyzing.
Is Nigeria's situation getting worse or better?
Both. Cases are rising—childhood cancers too. But there's infrastructure being built, telemedicine platforms connecting patients to doctors. The problem is the pace. Cases are rising faster than solutions are arriving.
What would actually change things?
Prevention, mostly. Stop smoking. Eat better. Move more. Vaccinate against HPV and hepatitis. Screen early. But also: money. Real investment in hospitals, equipment, training doctors. And political will to make it happen.